Abstract
Since the discovery of antibiotics, they have served as a potent weapon against bacterial infections; however, natural evolution has allowed bacteria to adapt and develop coping mechanisms, ultimately leading to the concerning escalation of multidrug resistance. Bacterial persisters are a subpopulation that can survive briefly under high concentrations of antibiotic treatment and resume growth after lethal stress. Importantly, bacterial persisters are thought to be a significant cause of ineffective antibiotic therapy and recurrent infections in clinical practice and are thought to contribute to the development of antibiotic resistance. Therefore, it is essential to elucidate the molecular mechanisms of persister formation and to develop precise medical strategies to combat persistent infections. However, there are many difficulties in studying persisters due to their small proportion in the microbiota and their non-heritable nature. In this review, we discuss the similarities and differences of antibiotic resistance, tolerance, persistence, and viable but non-culturable cells, summarize the molecular mechanisms that affect the formation of persisters, and outline the emerging technologies in the study of persisters.
Keywords: Antibiotic persistence, Persisters, Tolerance, Resistance, Persistent infections, Quorum sensing systems, Biofilms
Introduction
In bacterial populations, a small proportion of bacteria will enter a metabolically inactive or dormant state, either spontaneously or induced by environmental stress, and show high tolerance to a wide range of drugs [1]. In 1944, Bigger discovered that penicillin could not completely kill staphylococci in experiments and that the surviving colonies could still be effectively killed by penicillin after recultivation, leading to the first discovery of this subgroup, which he named “persisters” to distinguish them from drug-resistant mutants [2]. However, at that time, antibiotics were effective in treating bacterial infections, and new antibiotics were constantly being developed; the discovery of persisters did not receive attention. The presence of persisters has been found in a variety of bacteria (Table 1). The emergence of chronic infectious and inflammatory diseases has been on the rise since the beginning of the 21st century and has become a major public health problem worldwide [3]. There is increasing evidence of a strong association between persistent and persistent infections. For example, in a patient with cystic fibrosis, late isolates of Pseudomonas aeruginosa (P. aeruginosa) were 100-fold more persistent than early isolates [4]. Similarly, in Escherichia coli (E. coli), hipA mutant strains with high persistence were selected in patients with recurrent urinary tract infections [5]. In animal models, Patrick Kaiser and colleagues [6]used ciprofloxacin in Salmonella-infected mice. The results showed that high doses of ciprofloxacin killed most Salmonella within a few hours. However, at the end of the subsequent 10 days of treatment, approximately 10–20% of the bacteria remained viable in the cecum draining lymph node. In vitro experiments showed that the surviving cells were genetically susceptible to ciprofloxacin but significantly more tolerant [6]. Similar results were found in animal models of other studies [7]. These converging results suggest that persisters can cause chronic infections and are also selected for in the treatment of infections. In particular, recent results suggest that persistence emerges earlier than resistance under antibiotic treatment and may promote the development of resistance [8, 9].
Table 1.
Bacteria reported to form persisters and their related diseases
| Bacteria | Disease | Tools to analyze persistersa | References |
|---|---|---|---|
| Mycobacterium abscessus | Pneumonia | CFU | [10] |
| Mycobacterium smegmatis | microfluidic culture, time-lapse microscopy, and CFU | [11] | |
|
Mycobacterium tuberculosis |
Tuberculosis | CFU, SCRS, and transcriptomics | [12] |
| Mycobacterium marinum | Wound festers | CFU and microscopy | [13] |
| Mycobacterium bovis | Bovine tuberculosis | CFU | [14] |
| Acinetobacter baumannii | Respiratory and urinary tract infections | CFU | [15] |
| Bacillus subtilis | CFU and IFC | [16–18] | |
| Borrelia burgdorferi | Lyme disease | CFU and microscopy | [19, 20] |
| Brucella sp | Brucellosis | CFU | [21, 22] |
| Burkholderia cepacia |
Septicemia, pneumonia |
CFU | [23] |
| Burkholderia pseudomallei | Septicemia | CFU | [23] |
| Vibrio cholerae | Cholera | CFU and transcriptomics | [24] |
| Edwardsiella tarda | Gastroenteritis | CFU | [25] |
| Escherichia coli |
Diarrhea, extraintestinal infection, extraintestinal infection |
STM, CFU, SCRS, FACS, IFC, microfluidic culture, and microscopy | [26, 27, 18, 28] |
| Enterobacter aerogenes |
Urinary tract infection, respiratory tract infection |
CFU | [29] |
| Enterococcus faecium |
Neonatal sepsis, urinary tract infection |
CFU | [29] |
| Klebsiella pneumoniae | Pneumonia, bacteremia | CFU | [30] |
| Streptococcus mutans | Tooth decay | CFU and STM | [31] |
| Streptococcus suis |
Meningitis, bacteremia |
CFU | [32] |
|
Streptococcus pyogenes |
Pharyngotonsillitis, pneumonia |
CFU | [33] |
| Streptococcus pneumoniae |
Pneumonia, otitis media |
CFU | [34, 35] |
| Candida albicans |
Oral, gastrointestinal, and vaginal infections, Septicemia |
CFU | [36, 37] |
| Candida glabrata | CFU | [38, 39] | |
| Candida tropicalis | CFU and microscopy | [39, 40] | |
| Staphylococcus aureus | Osteomyelitis, endocarditis, infections of indwelling devices, and wound infections | CFU, FACS, and STM | [2, 41, 42] |
| Staphylococcus saprophyticus | Urinary tract infection | CFU and STM | [43] |
| Staphylococcus epidermidis |
Pyogenic infection, septicemia |
CFU | [44] |
| Listeria monocytogenes | Listeriosis | CFU and microscopy | [45, 46] |
| Salmonella Typhimurium | Acute gastroenteritis | CFU | [47] |
| Pseudomonas aeruginosa |
Chronic suppurative otitis media |
CFU | [48] |
aAbbreviations: CFU, colony-forming unit; SCRS, Single-cell Raman spectroscopy; FACS, fluorescence-activated cell sorting; IFC, imaging flow cytometry; STM, signature-tagged mutagenesis.
While persisters pose a significant public health and safety threat, they have also attracted much scientific interest in their characteristics and formation mechanisms. However, the percentage of persisters in the population is tiny, the offspring cannot inherit the persistent phenotype, and it is not easy to maintain the persistent phenotype during the research process, so there is no practical method to enrich the isolation of persisters, which is a significant obstacle to the research. In this paper, we present the phenotypic characteristics of persisters and the similarities and differences with a variety of other drug-resistant bacterial forms, which will help readers to fully understand persisters. Second, this paper reviews the recently reported mechanisms that induce persister formation and proposes a model in which the biofilm promotes persister formation and protects them, ultimately leading to persistent infections. Finally, we discuss biological research methods applied to the study of persisters at different scales according to the characteristics of persisters, and to the best of our knowledge, this is the first article to do so.
How bacteria resist antibiotics
Since their introduction, antibiotics have been an effective weapon against various bacterial infections. However, with the massive use of antibiotics, bacteria have gradually found many different ways to respond to ensure the continuation of populations, and the development of new antibiotics has many difficulties, so elucidating the multiple forms of bacterial resistance to antibiotics and making targeted responses to develop new precision medical strategies are essential measures to address global public health problems.
Persister cell
Persister cells are a subgroup of bacterial populations that are highly tolerant to a variety of antibiotics, which can survive the treatment of infections by tolerating antibiotics, and can re-proliferate after the effect of antibiotics disappears, resulting in prolonged therapy and disease recurrence (Fig. 1D) [1]. The phenotypic characteristics of persisters have been clearly described: First, persisters had the same minimum inhibitory concentration (MIC) as the susceptible (Fig. 1B). Second, the percentage of persisters in the population is tiny (usually less than 1%). Third, persisters are a transient phenotypic transformation; unlike drug-resistant bacteria, the genetic material of persister bacteria does not change, and the persisters that survive antibiotic killing are recultured and show the same antibiotic susceptibility as their parents [49] (Fig. 1C). When faced with the threat of antibiotics, the susceptible bacteria in the microbiota are killed first, while the subpopulation of persisters dies relatively slowly, so the change curve of the number of living bacteria over time will first show a rapid decline, after all the susceptible bacteria die, the decline rate decreases abruptly and gradually converges to the level (biphasic killing curves) (Fig. 1A) [49]. Persistent bacteria are usually considered to be in a “dormant” state, their growth is slow or stagnant [11, 50], and their metabolic level is reduced [51], thus protecting cellular processes. When the deleterious effects disappear, the survival environment is once again suitable, and persisters can be used as a “spark” of the microbiota to enrich the microbiota. However, it has also been shown that the percentage of persistent bacteria is significantly higher in slow-growing dormant cells, but most of the dormant cells are not persisters [52], so it cannot simply be assumed that persisters are dormant cells.
Fig. 1.
Physiological characteristics of resistant, tolerant, and persister cells. (A) Curves of the number of viable susceptible, persistent, tolerant, and resistant cells over time in the presence of lethal concentrations of antibiotics. (B) Persistent and tolerant bacteria had the same MIC as susceptible bacteria, while the MIC of resistant bacteria was significantly higher. The transition from a white to a black background represents a gradual increase in antibiotic concentration. (C) The process by which susceptible, tolerant, persistent, and resistant bacteria die when antibiotics are added and recover after removing antibiotics. Translucent cells represent dead cells. (D) Persistent bacteria exhibit a biphasic killing curve in response to the antibiotic killing and re-enriching the microbiota upon antibiotic removal. (Fig. 1A adapted from reference 49.)
Antibiotic resistant cell and tolerant cell
Resistant cells are bacteria that carry resistance factors by altering their genetic material and gaining the ability to prevent antibiotics from binding to their intended targets, for example, by mutating antibiotic target genes, altering the permeability of cell membranes or using efflux pumps to reduce intracellular drug concentrations, and directly destroying antibiotic structures so that drug resistance can be passed on to the next generation (Fig. 1C) [53]. The MIC of resistant bacteria was significantly higher compared to susceptible bacteria (Fig. 1B), and the resistance factor allowed resistant bacteria to grow in the presence of antibiotics at MIC concentrations of susceptible bacteria. Resistant bacteria are in a dominant position in natural selection, and the constant generation of mutations gives some resistant bacteria new resistance, generating multidrug-resistant bacteria, and even superbugs that are resistant to most antibiotics, which is undoubtedly a significant threat to global public health security.
Tolerant cells are bacteria that survive exposure to bactericidal antibiotics for a period of time. Unlike resistant bacteria, tolerant bacteria do not carry resistance factors and do not have an elevated MIC (Fig. 1B), but die significantly slower than susceptible bacteria at lethal concentrations of antibiotics (Fig. 1A and C) [49]. In short, killing resistant bacteria requires a longer duration of antibiotic action rather than a higher concentration of antibiotics. Similar to persistence, bacterial tolerance is often caused by slow bacterial growth [54], and both can survive for prolonged periods at concentrations of bactericidal antibiotics above the MIC, but persisters are a smaller proportion of subpopulations in the microbiota, whereas tolerance is for the microbiota as a whole [55].
Viable but non-culturable state
Viable but non-culturable (VBNC) cells are thought to be a survival strategy for bacteria in the face of adverse environmental changes, and bacteria can switch from an active to a VBNC state when stressed by environmental factors [56]. Bacteria that enter the VBNC state survive in a near dormant state and generally cannot grow on standard media, but have significantly improved tolerance to multiple antibacterial drugs [56, 57]. VBNC are similar to persisters in that both can survive environmental stress in a low metabolic state and are tolerant to a variety of antibiotics, but when the environment is restored to a condition suitable for bacterial growth, persisters will gradually recover and proliferate, while the recovery of VBNC often requires the stimulation of some specific factors, such as pyruvate and glutamate to promote the conversion of VBNC to a culturable state [58, 59]. Therefore, it has been suggested that the persisters and VBNC are homogeneous bacterial subgroups at different “dormancy depths“ [60].
Molecular mechanism of persister formation
There is no conclusive evidence on the mechanism of persister formation, but in recent years studies have shown a strong link between persister formation and the toxin-antitoxin (TA) systems, SOS response, Stringent response, (p)ppGpp signaling, adenosine triphosphate (ATP) depletion, biofilm, and quorum sensing (QS) bacterial communication.
Toxin-antitoxin systems
The toxin-antitoxin module consists mainly of stable toxins and unstable antitoxins cognate to them. Under normal conditions, toxins and antitoxins are kept in balance to maintain the normal physiological activities of cells [61]. The TA module is often described as a stress response element that is activated under stress [62], where partially unstable antitoxins are selectively degraded under the pressure of the survival environment, and the toxins exert their toxic effects interfering with critical cellular processes, leading to stagnation and dormancy of cells [63]. The TA system can be classified into six types according to the mechanism of neutralization of toxins by antitoxins [64]; it is now generally accepted that type I and type II TA modules, especially type II TA modules are closely associated with persister formation [62, 64, 65]. In E. coli, toxins in the type I TA modules TisB/istR, hokB/sokB, and Ghot/GhoS can insert into the bacterial inner membrane and thereby disrupting the proton-motive force that inhibits ATP synthesis and promotes persister formation (Fig. 2D) [66, 67]. The first gene identified to directly affect persistence is hipA from E. coli, which encodes the toxin portion of the type II TA module HipAB [68]. The hipA mutant hipA7 could increase the HipA: HipB ratio by affecting HipA to promote persister formation [68, 69]. HipA is a serine-threonine kinase that phosphorylates the aminoacyl tRNAglu synthetase GltX, the accumulation of uncharged tRNA at the ribosomal A site leads to the activation of RelA and an increase in (p)ppGpp alarmone (Fig. 2A) [70, 71], and (p)ppGpp regulates persister formation (see below). A related study showed that hipA7 mutants were selected in patients with recurrent urinary tract infections, providing strong evidence for a correlation between the hipA gene and persisters [5]. Similar to the action of HipA, a variety of type II TA modules can promote the production of persistence by inhibiting cellular translation (Fig. 2A). VapC can inhibit cellular translation by cleaving rRNA or tRNA molecules [72]; TacT can modify the primary amine group of amino acids charged onto tRNA molecules and block the formation of peptide bonds, thereby inhibiting translation. The activity of TacT on translation is counteracted by the action of Pth, which promotes the recovery of persisters [73]. RelE exhibits specific cleavage of mRNA high codons through binding to ribosomes [74, 75], and MazF can inhibit translation directly by cleaving mRNA and indirectly by reducing translation factors and promoting ribosomal dormancy [76]. In E. coli, overexpression of translationally inhibitable toxins (RelE and MazF) increases the proportion of persisters [64, 77].
Fig. 2.
The main molecular mechanisms that induce the formation of persisters. (A) Most of the toxins in the type II TA modules can act as translation inhibitors, inhibiting cellular translation and inducing the formation of persisters by cutting mRNA, cutting tRNA, phosphorylating amino acid tRNA synthetase, modifying tRNA molecules, and many other ways. (B) The Stringent response can be triggered by various factors such as pH change, heat shock, and nutrient restriction, and is mainly mediated by (p)ppGpp. (p)ppGpp is produced by RelA or SPoT; it can affect the formation of persisters by modulating multiple type I and type II TA modules; however, in the absence of triggering factors, SPoT can inhibit (p)ppGpp production, keeping (p)ppGpp at a low level. (C) Cellular DNA damage induced by antibiotic exposure, oxidative stress, etc. The single-stranded DNA produced by the damaged DNA replication will activate the SOS response, which in turn will lead to the toxins of certain type I TA modules exerting their toxic effects. (D) The toxin of the type I TA modules can be inserted into the cell membrane and disrupt the proton-motive force that inhibits ATP synthesis. The rounded blue rectangles in the figure represent toxins (their corresponding antitoxins are not shown), the blue arrows represent facilitated persistence, and the red arrows represent diminished persistence
Although many studies have reported the relationship between the toxin-antitoxin system and persisters, its role in persister formation remains controversial. Either reduction of ATP synthesis or inhibition of translation slows cell growth, and slow-growing cells exhibit greater antibiotic tolerance. Therefore, any factor that contributes to slowing cell growth (e.g., overexpression of most toxins) would be expected to increase persistence. Vazquez et al. [78]. showed that overexpression of unrelated proteins, such as DnaJ and PmrC, also reduced cell growth and that cells overexpressing these proteins had higher survival rates when challenged with ciprofloxacin and ampicillin, which is similar to the results of overexpressing certain toxins, such as HipA [78]. Unfortunately, biphasic killing curves were not determined in this study, making it impossible to directly attribute increased survival to increased persistence [78]. It should be noted that Goormaghtigh and colleagues [79]knocked down 10 TA modules in E. coli and found no significant effect on their persistence, which could be explained by the very large functional redundancy of the TA modules on persistence. It is now well established that the toxin-antitoxin system acts as a stress response module that shares similar upstream triggers with persister formation: e.g., nutrient depletion and pH changes [80]. As to whether the toxin-antitoxin system plays a regulatory role in persister formation requires further study.
Stringent response and (p)ppGpp signaling
The stringent response is a stress response triggered mainly by nutrient restriction (amino acid or fat depletion, etc.) and is regulated by both guanosine tetrakisphosphate (ppGpp) and guanosine pentakisphosphate (pppGpp). (p)ppGpp synthase RelA is activated by amino acid starvation and heat stress [81], while SpoT has a dual function of synthesis and hydrolysis, carbon, nitrogen, phosphate, iron, and fatty acid starvation will activate SpoT to produce (p)ppGpp [82], while under favorable conditions SpoT will keep (p)ppGpp at low levels (Fig. 2B) [81]. In E. coli, (p)ppGpp directly inhibits DNA primase and also targets a variety of proteins involved in lipid metabolism and nucleotide metabolism [83, 84], and can inhibit rRNA synthesis by regulating the transcription of the ribosomal regulatory factor (Rmf), which in turn affects global cellular translation [85]. (p)ppGpp also regulates the TA system; for example, increased levels of (p)ppGpp due to amino acid starvation will upregulate multiple type II TA modules, including hipAB, dinJ/yafQ, mazEF, mqsRA, relBE, and yafNO [27, 86, 87], as well as the type I TA module hokB (Fig. 2B) [66]. Mutants lacking relA, relA and spoT typically form fewer persisters due to reduced levels of (p)ppGpp [88]. In conclusion, (p)ppGpp can reprogram cellular life activities to adapt to harsh survival environments through transcriptional reprogramming and direct regulation of target protein activity, and these changes will result in slow cell growth or dormancy.
SOS response
When bacteria are exposed to various adverse environments (oxidative stress, extreme pH, bactericidal antibiotics), they are prone to DNA damage, which in turn triggers the SOS response [50, 89]. When DNA damage occurs, RecA proteins are activated by the single-stranded DNA produced by processing the damaged DNA, inducing the SOS response (Fig. 2C) [90]. The role of the SOS response in persister formation has been reported in several species, including Escherichia coli [91], P. aeruginosa [92], Staphylococcus aureus (S. aureus) [93], and Mycobacterium tuberculosis (M. tuberculosis) [94]. The SOS response serves as a stress signaling pathway that activates type I (tisB/istR-1, symE/symR, diQ/agrB, hokE/sokE) and type II (yafNO, dinJ/yafQ) TA modules, allowing toxins to exert their toxic effects and inducing the production of persisters [90, 91, 95–97]. For example, in E. coli, the SOS response can cause the cleavage of the SOS gene blocker LexA, which inhibits the toxin TisB of the tisB/istR-1 module, thus causing the accumulation of free TisB. TisB is a small hydrophobic peptide, and the insertion of TisB into the inner membrane depolarizes the inner membrane, disrupts the proton-motive force that inhibits ATP synthesis, and induces bacterial dormancy and persister formation (Fig. 2C) [98, 99]. The effect of the SOS response on persistence was also demonstrated by the reduced production of persisters in the tisB deficient strain and the increased proportion of persisters in the istR-1 deficient strain under the influence of antibiotic stress [91, 100].
Impact of global regulators on persisters
Several recent studies have shown that global regulators can affect the production of persisters in different ways. Obg is a GTPase that regulates ribosome function and is involved in DNA and protein synthesis. Verstraeten and his team showed that a central role for Obg in determining persistence in response to nutrient starvation [66]. In E. coli, Obg, with the involvement of (p)ppGpp, affects the transcription of the type I toxin-antitoxin module hokB-sokB [66, 101], and increased levels of Obg induces the expression of HokB, which has similar properties to TisB, both of which insert into the cell membrane leading to PMF disruption and decreased ATP synthesis, inducing the formation of persisters [66]. PhoU is a negative global regulator that, beyond its role in phosphate metabolism, facilitates persister formation by suppressing many critical cellular metabolic processes [102]; PhoU deficiency results in increased cellular metabolic activity, increased expression of energy-producing genes, and reduced persistence [102]. RpoS is a global regulator that plays a vital role in the general stress response that is triggered by nutrient deprivation, temperature changes, pH extremes, oxidative stress, etc. It is a key molecular mechanism that enables bacteria to survive under pressure; RpoS can replace σ-factors in the transcriptional reprogramming of bacteria and generally increase the stress tolerance of the population [103]. Upregulated RpoS expression has been found under stress conditions, accompanied by increased population persistence [104]. Recent studies by Kim Lewis’ team have shown that the integration host factor (IHF) reduces cellular ATP levels by regulating the expression of key enzymes at the junction of the tricarboxylic acid (TCA) cycle and the glyoxalate bypass, shifting carbon from efficient energy production to carbon conservation pathways and thereby promoting the formation of persisters [105]. In Salmonella, Fis regulates persistence by modulating glutamate metabolism [106]. Similarly, in Salmonella typhimurium, the RNA-binding protein ProQ was reported to be a global regulator of gene expression, which promotes the formation of persistent bacteria by activating energy-consuming processes that include flagellar motility and protein secretion [107]. The global regulators reported so far can affect persistence in many ways rather than through a defined pathway, suggesting that complex, diverse, and redundant regulatory mechanisms affect persistence.
ATP depletion
The TA systems, as well as the general stress response, were thought to be the best possible candidate to explain the persistence phenomenon; however, this speculation has recently been challenged [41, 79]. Based on the phenomenon of low nutrient levels during the plateau phase of bacterial growth and a significantly higher proportion of persisters during the plateau phase than during the exponential phase, the researchers propose the theory that fluctuations in ATP depletion mediate the production of persisters. In S. aureus, Eliza A. Zalis and colleagues constructed several key TAC cycle enzyme deficient strains and demonstrated that the TAC cycle enzyme deficient strains were significantly more capable of forming persisters than wild-type strains and that the high persistence strains had lower ATP levels [108]; in contrast, knocking out the TA module and (p)ppGpp synthase in S. aureus had no significant effect on persistence [41]. Natural fluctuations in the expression levels of genes controlling energy production have been reported to influence the formation of M. tuberculosis persisters [109]. Similar results were found in E. coli, where a reduction in ATP levels by arsenate treatment increased persistence [27]. Similarly, treatment with cyanide-m-chlorophenylhydrazone (CCCP) (a metabolic inhibitor) significantly increased the proportion of persisters in the colony [110]. ATP levels have not been found to affect persistence through a specific pathway, and it is speculated that lower intracellular ATP levels may down-regulate critical central cellular physiological processes (e.g., transcription, translation), leading to inactivation of antibiotic targets, and thus multi-drug tolerance in bacteria. Besides, a recent study has shown that reduced ATP levels lead to the accumulation of insoluble proteins in the cell, promoting the transformation of sensitive cells into persisters, which may also be one of the reasons why ATP affects persistence levels [60].
Bacterial communication
Quorum sensing (QS) is a bacterial communication network that allows bacteria to transmit information by secreting autoinducers as signaling molecules that manage the investment of community resources into phenotypically distinct subpopulations, allowing colonies to exhibit uniform behavior conducive to population survival in adapting to their environment, resisting hazards, and competing with other species [111–114]. There is increasing evidence that QS, as well as intercellular chemical signaling molecules, play an essential role in establishing heterogeneity in bacterial populations [115–119]. Suppose persisters are considered to be strategies used by bacterial populations to enhance the colony’s response to environmental risks and to ensure that the colony does not go extinct in the event of a sudden environmental change; in that case, then it is clear that QS, as the language of bacteria, has a regulatory role in the formation of persisters. For example, in S. aureus, the Agr quorum sensing system represses persister formation through regulation of phenol soluble modulins [115]; P. aeruginosa responds to the population-sensing signal molecule acyl-homoserine lactone to increase the proportion of persisters in the colony [120]; the stress-inducible quorum-sensing peptide CSP (competence-stimulating peptide) can induce the formation of Streptococcus pyogenes persisters [118, 121].
Similarly, intercellular signaling molecules have been shown to be involved in the regulation of persistence. Indole is an intercellular signaling molecule that, unlike QS signaling molecules, can regulate bacterial population behavior through either persistent or pulsed signaling modes [122]. Whereas QS regulates gene expression in response to fluctuations in cell population density, QS signaling molecules increase with cell density, and cells sense their concentration to regulate gene expression [123]. In particular, the role of indoles in the formation of persisters is the subject of much controversy. The results of Nicole M. Vega et al. showed that in E. coli, the proportion of persisters incubated with indole (500 µM) increases by at least an order of magnitude [124], tnaA encodes a protein that converts tryptophan to indole. tnaA deficient strain contains very little indole and is almost an order of magnitude less able to form persisters [124]. The results of Manon Lang et al. also showed that indole (350µM) increased the persistence of Vibrio cholerae to aminoglycoside antibiotics [24]. On the contrary, some other findings suggest that indole (1–2 mM) may reduce persistence [125, 126], and 1–2 mM is considered a toxic concentration [24]. In summary, we believe that the effect of indole on persistence may depend on its concentration.
Bacterial biofilms
Bacterial biofilms refer to the proliferation and differentiation of bacteria adhering to inert or active surfaces formed by communities embedded in a self-produced matrix of extracellular polymeric substances [127]. Biofilms can block a variety of bactericidal antibiotics and other immune substances, protect the bacteria from a variety of adverse conditions, including immune response, and improve the survival of the bacteria [128, 129]. However, some antibiotics can easily penetrate the biofilms and still can not achieve an excellent bactericidal effect [130]; therefore, the higher tolerance of biofilms to antibiotics has been attributed to the persisters within them [130–133]. The biofilm matrix surrounds the cells, providing a protective barrier while impeding the cell’s access to nutrients and oxygen. Hypoxia and nutrient depletion can promote the formation of persisters through several different mechanisms e.g. (p)ppGpp, intercellular communication, and SOS induction [134]. Different research groups have detected the enrichment of persisters under a variety of common bacterial biofilms [4, 135–137]. Lewis proposed the model that biofilm causes the recurrence of infection [1, 138], and based on this; we added that the biofilm environment promotes the formation of persisters through different mechanisms. Figure 3 depicts the model that biofilm promotes the enrichment of persisters and causes the recurrence of infection (Fig. 3) [1, 138].
Fig. 3.
A model of biofilms promoting the production of persisters and causing persistent infection. When the biofilms begin to form, bacteria within the biofilms are subjected to environmental conditions such as nutrient limitation and hypoxia, triggering the stringent response and the SOS Response, leading to an increase in persistent bacteria within the biofilms, and intercellular communication further facilitates this process. In the face of antibiotic treatment, susceptible bacteria inside and outside the biofilms are killed, and the organism’s immune defense can kill the persisters outside the biofilms, but the action of the biofilm hinders the killing of the persisters inside the biofilms by the immune defense, and when the antibiotic treatment disappears, the surviving persisters inside the biofilms will recover and re-enrich the bacterial population
Approaches and methods for studying persistence
Detection of antibiotic persistence
According to the present study, no specific molecular markers or phenotypic characteristics of the persisters were found to distinguish the susceptible bacteria, and the distinction of persistence was mainly based on the time-kill assay, which determines the survival of bacteria at different time points during antibiotic exposure [55]. Survival is defined as the ability to regrow after antibiotic removal. The hallmark of persistence is the bimodal (or multimodal) killing curve, which represents the presence of two (or more) subgroups of cells with different susceptibilities to antibiotics (Fig. 1A). However, to confirm that one of the subgroups is persisters, effects such as drug-resistant mutants, tolerance phenotypes, and changes in the killing capacity of the drug with time degradation should also be avoided [49].
Methods for the enrichment of persisters at the population level
In the natural state of actively growing microbiota, the proportion of persisters is small, they are not heritable and lack a unique molecular identity, making it difficult to accurately separate persisters from susceptible and drug-resistant bacteria and to obtain sufficient samples for research [28, 55]. Therefore, specific methods can be used to induce the generation of persisters to increase their proportion in the microbiota.
As a bacterial survival strategy in response to environmental stress, persisters can form randomly in normally growing colonies or be induced by various factors (Fig. 4). Depending on the mode of formation, persisters can be classified as Type I or Type II persisters, also known as triggered persisters or spontaneous persisters [49]. When the bacteria are in a steady state of exponential growth, a part of the population will be converted into persisters at a constant rate, called Type II persisters. The production of Type I persisters requires specific triggers, which are usually environmental stresses that are detrimental to the microbiota, such as biofilm (Fig. 4D) [139], phagocytosis of immune cells (Fig. 4B) [140], nutrient starvation [141], pH changes [142], oxidative stress [143], antibiotic treatment [1] (Fig. 4E). The level of Type I persisters is related to the nature and duration of the environmental stress.
Fig. 4.
Different factors that promote persister formation. (A) Part of the exponentially growing microbiota is randomly converted into persisters. (B) In the host, phagocytosis of immune cells promotes the formation of persisters. (C) The proportion of persisters in the stationary phase microbiota increases significantly. (D) Biofilm environment encourages the conversion of normal microbiota into persisters. (E) Antibiotic treatment, starvation, pH changes, oxidative stress, carbon source conversion, and treatment with metabolic inhibitors have promoted the transformation of normal microbiota to persisters
Nutrient starvation is one of the most common environmental factors that promote persister formation, where bacterial nutrient levels are lower during the plateau growth phase and the proportion of persisters in the colony is significantly higher than during the exponential growth phase [134]. Therefore, reducing nutrient levels by prolonged incubation is an easy way to enrich persisters. In a long-term culture test of E. coli, it was found that the proportion of persisters was significantly higher in 24-hour cultures compared to exponential growth period cultures [60]. In addition, some metabolic inhibitors can significantly increase the proportion of persisters in the colony; for example, CCCP or arsenate incubation significantly increased the proportion of persisters in E. coli [60], S. aureus [41]and P. aeruginosa [48].
Enrichment of persisters can be achieved by using antibiotics to lyse growing bacteria. For example, E. coli is treated with ampicillin, and the surviving persisters are collected by centrifugation [144]; and the lysis of M. tuberculosis by D-cycloserine enables the enrichment of persisters (Fig. 5C) [145]. Enrichment of persisters by antibiotic lysis of growing bacteria is simple and reproducible, and the harvested persisters can be used for downstream analyses such as transcriptomics. However, not all antibiotics lyse bacteria after killing them. In addition, exogenous antibiotics affect the expression of bacterial genes, and it cannot be excluded that the detected differential genes are the result of antibiotic action. However, due to the lack of methods to enrich for persisters without interfering with bacterial growth, the similar transcriptome results are still of high research value.
Fig. 5.
Main methods used to study persisters. We list a selection of articles that either applied these methods to persister studies for the first time or made important advances in persister studies using these methods, and indicate the combinations of methods they used with a green line, with single-cell techniques shown in light green background panels and non-single cell techniques shown on a white background. (A) Using an antimicrobial drug-induced approach, the Lewis team [68] screened for mutant strains with significantly increased persistence and localized the mutant genes. (B) Jan Michiels’ team [146] discovered the rapid evolution of persistence in E. coli during repeated antibiotic treatments and used whole-genome sequencing to show that this evolution was driven by a single-point mutation in a few genes. (C) Similarly, the Lewis team [144, 145] uses antimicrobial agents to lyse sensitive bacteria and collect persisters by centrifugation for subsequent studies. (D) The Lewis team [41, 108] combined fluorescent reporter protein genes with energy production-related genes and found that persister formation was associated with a decrease in ATP levels by FACS analysis. E) Based on the construction of fluorescence-expressing strains, Theresa C. Henry’s team [147] used FACS in conjunction with transcriptomics to study the physiology of persisters. (F) Sophie Helaine’s team [140] used fluorescent protein expressing strains to infect host cells, which were sorted by FACS, and then used dual RNA-seq to simultaneously detect transcriptome changes in both the persisters and host cells, and found that the persisters had a disruptive effect on host immunity during infection. (G) Balaban’s group [148] has developed a method of monitoring changes in colony appearance that can be used to study the time it takes for persisters to return to their normal proliferative state. (H) Balaban’s team [26] uses microfluidic culture for the first time to study persisters.
Application of single-cell technology in the investigating of persisters
Flow cytometry
Flow cytometry is a technique for the rapid characterization of small biological particles, such as bacteria. It is an advanced method commonly used in biological research to characterize these biological features at the single-cell level by rapidly detecting photons emanating from individual cells and thus quantifying various essential parameters such as size, granularity (the material inside the cell), and various fluorescent properties of the cell.
The advent of fluorescence-activated sorting has provided a major boost to the development of flow cytometry. Cells with a desired fluorescence characteristic can be differentially charged and isolated using electrical currents and electromagnetic devices. This technique plays an important role in the study of bacterial phenotypic heterogeneity by allowing the isolation of single cells for subsequent studies. In the absence of techniques to separate persistent bacteria from other cell types, fluorescence-activated cell sorting (FACS) has become the gold standard for examining persisters’ physiology [52, 149]. Mohiuddin and colleagues use fluorescent cell-activated sorting combined with a fluorescent protein expression system to monitor the recovery process of persisters at the single-cell level [150]. Eliza A. Zalis et al. linked the green fluorescent protein gene to several TCA cycle enzyme genes and used fluorescence-activated cell sorting to achieve enrichment of persistent bacteria, confirming that persister formation is associated with ATP levels regulated by the TCA cycle (Fig. 5D) [108]. Vivek Srinivas and colleagues developed the PerSort system based on fluorescence-activated cell sorting to isolate M. tuberculosis persisters from normally growing M. tuberculosis by measuring cell translation levels [151], Similarly, Theresa C. Henry et al. developed Persister-FACSeq by combining FACS and next-generation sequencing technologies and applied it to study persister physiology and its heterogeneity(Fig. 5E) [147]. To obtain more information about cell morphology, flow cytometry can be combined with fluorescence microscopy, a technique known as imaging flow cytometry (IFC), which provides fluorescence-indicated morphological and physiological information in the context of a single cell by capturing multiple images as the cells pass through, compared to traditional flow cytometry. The high-throughput information collection and image capture capabilities of IFC have been effective in studying the physiological properties of quiescent cells [152] and in monitoring the recovery of persisters after antibiotic treatment [18]. Much of the difficulty in studying persisters lies in the inability to obtain sufficient samples for study, as persisters are subpopulations of the flora and represent a relatively small proportion of the population. Fluorescence-activated sorting, which allows the physical isolation of persisters, has advanced the development of persister research. However, it cannot be ignored that this method has some limitations. First, fluorescence-activated sorting is highly dependent on specific fluorescent markers, but relatively few fluorescent reporter genes have been successfully used to characterize and isolate persisters [108, 151, 153–155]. In addition, the process of fluorescence-activated sorting is complicated and tedious, while the physiological characteristics of persisters are reversible, and the characteristics of persisters may change during the sorting process.
Microfluidic cultures and time-lapse microscopy
Microfluidic devices have greatly improved the ability of microscopy to analyze persisters, allowing individual cells to be monitored for long periods under ideal bacterial growth conditions [124]. Microfluidic devices allow monitoring of the process by which persisters revert to sensitized bacteria and begin to proliferate, providing a new perspective on controlling persistent infections caused by persisters. Persistent infections can be controlled by preventing persisters from recovering and proliferating, or by inducing them into deeper “dormancy depths“ [60]. Balaban et al. were the first to apply microfluidic culture to the study of persistence and observed type I and type II persisters of E. coli at the single-cell level for the first time(Fig. 5H) [26], then Orit Gefen and colleagues used a microfluidic device to monitor the synthesis of fluorescent proteins under a synthetic promoter to characterize the dormancy of individual persisters and found that exposure of bacteria to antibiotics at specific stages significantly reduced persistence [156]. Nicole M Vega et al. used microfluidic culture to monitor indole-induced persistence formation and determined the role of oxidative stress and phage shock pathways in this phenomenon [124]. Subsequently, Yuichi Wakamoto et al. combined microfluidic culture with time-lapse microscopy to monitor the killing of Mycobacterium smegmatis by isoniazid (INH) at the single-cell level and found that Mycobacterium smegmatis produces persisters by division in the presence of INH [11]. Based on time-lapse imaging, Balaban’s team developed the ScanLag technology, which measures in parallel the delay in growth (lag time) and growth rate of thousands of cells; this has important implications for monitoring persisters’ formation and recovery process(Fig. 5G) [148]. Similarly, with the rapid development of microscopic resolution, Yingying et al. used high-throughput light microscopy to monitor the recovery process of persisters. They found the existence of “dark foci” (protein aggregates) in persisters and the difference in the time required for recovery of persisters which led to the concept of “dormancy depth.” and demonstrated that dynamic protein aggregation regulated by ATP can regulate the dormancy depth of bacteria and significantly affect the tolerance of bacteria [60]. Microfluidic devices and time-lapse microscopy allow monitoring of individual cells over long periods of time, but the higher accuracy limits the number of targets that can be monitored simultaneously. However, time-lapse microscopy makes it difficult to accurately find persisters due to the small percentage of persisters in the colony. This problem can be solved by combining flow cytometry for initial isolation of persisters, followed by monitoring and analysis of individual cells using microfluidic culture and time-lapse microscopy.
Single-cell Raman Spectroscopy
Single-cell Raman Spectroscopy (SCRS) is a non-invasive technique for characterizing the physiological properties of individual cells, which uses a monochromatic laser as a light source to penetrate cells to obtain cellular Raman spectra [157]. When laser light is transmitted to proteins, lipids, sugars, and other substances in the cell, the scattered light signal can be expressed as different specific spectra, which are like molecular “fingerprints” of particular substances, and the full spectrum of the cell can reflect the physiological state and intrinsic characteristics of the cell. SCRS can be used for many studies, such as the detection of cellular metabolites [158], the detection of cellular metabolic state, the determination of bacterial antibiotic resistance [159, 160], and the characterization of single-cell phenotypic diversity of microbial populations with non-destructive and label-free characteristics [161]. Currently, several reports describe the survival mechanism of persistence as entering a metabolically inactive state of growth inhibition under environmental stress, but recent studies by two different groups have reached different conclusions; Chuan Wang et al. used SCRS in combination with D2O labeling (D2O-Ramanometry) and found that E. coli persisters exhibited more vigorous metabolic activity [162]. Hiroshi Ueno used SCRS to analyze the metabolic activity of persisters under antibiotic treatment with rifampicin and confirmed that dormancy was not the cause of persister production in M. tuberculosis [12]. As persistence studies deepen, I believe more researchers will realize the advantages of SCRS, a non-invasive method that does not easily disrupt the phenotypic state of cells, making it a promising development in persistence studies.
Advances in persistence genes
The search for genes associated with persister formation is one of the essential approaches to study bacterial persistence mechanisms. However, due to the non-heritable nature of persisters, the study of persistence-related genes was not initially emphasized until 1983 when Moyed and Bertrand used chemical induction and antimicrobial killing to screen for the first mutant strain with significantly improved persistence and localized the mutant gene in hipA [68]. Screening for strains with significant changes in persistence levels by constructing deletion, overexpression, or mutagenesis libraries became the first approach to studying persistence genes (Fig. 5A). Transcriptomics allows the analysis of global transcriptional changes in persisters. For example, using the effect of lysis of non-persistent M. tuberculosis bacteria by D-cycloserine and collection of surviving cells by centrifugation, and the transcriptomes of persistent bacteria can be obtained by hybridization to Affymetrix array [145]. RNA sequencing (RNA-seq) significantly increases the range and sensitivity of transcript detection compared to microarrays, which has greatly facilitated the development of transcriptomics [163]. Using dual RNA-seq methods, Helaine’s group sequenced the transcriptomes of Salmonella persisters and the host cells in which they reside during persistent infections(Fig. 5F) [140]. Michiels’ team reveals rapid evolution and adaptation of persistence during antibiotic treatment and uses whole-genome sequencing to locate mutant genes that cause high persistence(Fig. 5B) [146]. With the advancement of gene sequencing technology and the reduction of cost, next-generation sequencing (NGS) technology can provide a comprehensive analysis of genetic and transcriptomic information [164], especially single-cell sequencing technology can study rare genetic differences that are easily overlooked in populations and is suitable for studying phenotypic heterogeneity.
Conclusion and prospect
In the past 20 years, with the rapid development of bacterial drug resistance, the study of persistent bacteria has gradually gained attention. In particular, during the treatment of cancer, a small proportion of cancer cells survive after drug treatment without resistance mutations, which exhibit reduced cell cycle kinetics and transient tolerance to toxic treatment [165, 166]. This way in which cancer cells adapt to environmental stress by changing their phenotype shows a high degree of similarity to persisters [167] and may therefore explain the emergence of both by similar mechanisms. The critical role of persistence in the recurrence of chronic infections, the generation of global AMR, and in cancer treatment has attracted great interest from researchers, and many advances have been made.
Current research suggests that the causes of persistence are complex and highly redundant and that no single mechanism can completely control the formation of persistent bacteria. Recent research has shown that multiple mechanisms, including toxin-antitoxin systems, SOS response, stringent response, and numerous global regulators, are involved in the formation of persistent bacteria by reducing cellular ATP levels, impeding DNA replication, inhibiting translation, and inducing protein accumulation in various forms. However, there are still many unanswered questions regarding the molecular mechanisms of bacterial persistence and its clinical manifestations, such as the upstream mechanisms for sensing environmental changes and making decisions are not clear; is the emergence of persistent bacteria in a suitable environment simply the result of random differences in gene expression levels? In the context of clinical treatment, how can the emergence of persistence in patients be measured in vivo? How do the host’s in vivo environment and immune system interact with persistent bacteria? How homogeneous are persistent bacteria in vivo versus in vitro? What is clear, however, is that phenotypic heterogeneity, influenced by multiple mechanisms, is critical for the survival of the microbiota.
Currently, it is widely recognized that single-cell technology plays an important role in the study of persisters. This is because further studies on persisters require their precise isolation. Emerging single-cell technologies such as fluorescence-activated cell sorting (FACS), imaging flow cytometry (IFC), microfluidic culture, and single-cell Raman spectroscopy (SCRS) are increasingly used in the study of bacterial phenotypic heterogeneity. However, it is undeniable that they still have limitations such as the lack of specific markers and the growth and complexity of the sorting process. It is believed that shortly, breakthroughs in advanced technologies will soon solve many of these problems that still exist in the study of persistence.
Abbreviations
- AMR
antimicrobial resistance
- MIC
minimum inhibitory concentration
- VBNC
viable but non-culturable cells
- TA
toxin-antitoxin
- QS
quorum sensing
- ATP
adenosine triphosphate
- TCA
tricarboxylic acid
- CCCP
cyanide m-chlorophenylhydrazone
- CSP
competence-stimulating peptide
- FACS
fluorescence-activated cell sorting
- IFC
imaging flow cytometry
- INH
isoniazid
- SCRS
Single-cell Raman Spectroscopy
- NGS
next-generation sequencing
Author contributions
Y.W. designed the concept of the review article. S.Y., Y.M.S., Y.Y.Q., S.J.G., and J.Z. contributed to writing the manuscript. R.S.L.,W.J.J., L.Y.,and Y.X.W.critically read and corrected the manuscript. All authors read and approved the final manuscript.
Funding
This research was financially supported by the National Natural Science Foundation of China (32172852), Excellent Youth Foundation of Henan Scientific Committee (222300420005), Henan Provincial Science and Technology Research Project (232102110095), Program for Innovative Research Team (in Science and Technology) in University of Henan Province (24IRTSTHN033) and Key Scientific Research Projects of Universities in Henan Province (24A230013).
Data availability
No datasets were generated or analysed during the current study.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Shuo Yuan and Yamin Shen contributed equally to this work.
References
- 1.Lewis K. Persister cells. Annu Rev Microbiol. 2010;64:357–72. [DOI] [PubMed] [Google Scholar]
- 2.Bigger JW. TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION. Lancet. 1944;244:497–500. [Google Scholar]
- 3.GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Lond Engl. 2020;396:1223–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mulcahy LR, Burns JL, Lory S, Lewis K. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol. 2010;192:6191–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schumacher MA, Balani P, Min J, Chinnam NB, Hansen S, Vulić M, et al. HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature. 2015;524:59–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kaiser P, Regoes RR, Dolowschiak T, Wotzka SY, Lengefeld J, Slack E, et al. Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol. 2014;12:e1001793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.B C PS. A C, N P, J Z, N S, Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell. 2014;158. [DOI] [PubMed]
- 8.Levin-Reisman I, Ronin I, Gefen O, Braniss I, Shoresh N, Balaban NQ. Antibiotic tolerance facilitates the evolution of resistance. Science. 2017;355:826–30. [DOI] [PubMed] [Google Scholar]
- 9.Liu J, Gefen O, Ronin I, Bar-Meir M, Balaban NQ. Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science. 2020;367:200–4. [DOI] [PubMed] [Google Scholar]
- 10.Yam Y-K, Alvarez N, Go M-L, Dick T. Extreme Drug Tolerance of Mycobacterium abscessus Persisters. Front Microbiol. 2020;11:359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wakamoto Y, Dhar N, Chait R, Schneider K, Signorino-Gelo F, Leibler S, et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science. 2013;339:91–5. [DOI] [PubMed] [Google Scholar]
- 12.Ueno H, Kato Y, Tabata KV, Noji H. Revealing the metabolic activity of persisters in Mycobacteria by single-cell D2O Raman Imaging Spectroscopy. Anal Chem. 2019;91:15171–8. [DOI] [PubMed] [Google Scholar]
- 13.Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 2011;145:39–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mukherjee D, Zou H, Liu S, Beuerman R, Dick T. Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development. Future Microbiol. 2016;11:643–50. [DOI] [PubMed] [Google Scholar]
- 15.Que Y-A, Hazan R, Strobel B, Maura D, He J, Kesarwani M, et al. A quorum sensing small volatile molecule promotes antibiotic tolerance in bacteria. PLoS ONE. 2013;8:e80140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hahn J, Tanner AW, Carabetta VJ, Cristea IM, Dubnau D. ComGA-RelA interaction and persistence in the Bacillus subtilis K-state. Mol Microbiol. 2015;97:454–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bareia T, Pollak S, Eldar A. Self-sensing in Bacillus subtilis quorum-sensing systems. Nat Microbiol. 2018;3:83–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Power AL, Barber DG, Groenhof SRM, Wagley S, Liu P, Parker DA, et al. The application of Imaging Flow Cytometry for Characterisation and quantification of bacterial phenotypes. Front Cell Infect Microbiol. 2021;11:716592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Feng J, Auwaerter PG, Zhang Y. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS ONE. 2015;10:e0117207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y. A drug combination screen identifies drugs active against Amoxicillin-Induced Round bodies of in Vitro Borrelia burgdorferi persisters from an FDA Drug Library. Front Microbiol. 2016;7:743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ficht TA. Intracellular survival of Brucella: defining the link with persistence. Vet Microbiol. 2003;92:213–23. [DOI] [PubMed] [Google Scholar]
- 22.Abdou E, Jiménez de Bagüés MP, Martínez-Abadía I, Ouahrani-Bettache S, Pantesco V, Occhialini A, et al. RegA plays a key role in oxygen-dependent establishment of persistence and in Isocitrate Lyase Activity, a critical determinant of in vivo Brucella suis pathogenicity. Front Cell Infect Microbiol. 2017;7:186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nierman WC, Yu Y, Losada L. The in vitro antibiotic tolerant Persister Population in Burkholderia pseudomallei is altered by environmental factors. Front Microbiol. 2015;6:1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lang M, Krin E, Korlowski C, Sismeiro O, Varet H, Coppée J-Y, et al. Sleeping ribosomes: bacterial signaling triggers RaiA mediated persistence to aminoglycosides. iScience. 2021;24:103128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Su Y, Peng B, Han Y, Li H, Peng X. Fructose restores susceptibility of multidrug-resistant Edwardsiella tarda to kanamycin. J Proteome Res. 2015;14:1612–20. [DOI] [PubMed] [Google Scholar]
- 26.Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. Bacterial persistence as a phenotypic switch. Science. 2004;305:1622–5. [DOI] [PubMed] [Google Scholar]
- 27.Shan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K. ATP-Dependent persister formation in Escherichia coli. mBio. 2017;8:e02267–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang C, Jin L. Microbial persisters and host: recent advances and future perspectives. Crit Rev Microbiol. 2022;:1–13. [DOI] [PubMed]
- 29.Michiels JE, Van den Bergh B, Verstraeten N, Fauvart M, Michiels J. In Vitro Emergence of High Persistence upon periodic Aminoglycoside Challenge in the ESKAPE pathogens. Antimicrob Agents Chemother. 2016;60:4630–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ren H, He X, Zou X, Wang G, Li S, Wu Y. Gradual increase in antibiotic concentration affects persistence of Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70:3267–72. [DOI] [PubMed] [Google Scholar]
- 31.Wang S, Zhou C, Ren B, Li X, Weir MD, Masri RM, et al. Formation of persisters in Streptococcus mutans biofilms induced by antibacterial dental monomer. J Mater Sci Mater Med. 2017;28:178. [DOI] [PubMed] [Google Scholar]
- 32.Willenborg J, Willms D, Bertram R, Goethe R, Valentin-Weigand P. Characterization of multi-drug tolerant persister cells in Streptococcus suis. BMC Microbiol. 2014;14:120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cl M, Az C, Mcn M, Cn G, Ús L, Mc de M et al. Cellular Growth arrest and efflux pumps are Associated with Antibiotic persisters in Streptococcus pyogenes Induced in Biofilm-Like environments. Front Microbiol. 2021;12. [DOI] [PMC free article] [PubMed]
- 34.Geerts N, De Vooght L, Passaris I, Delputte P, Van den Bergh B, Cos P. Antibiotic Tolerance Indicative of persistence is pervasive among clinical Streptococcus pneumoniae isolates and shows strong Condition Dependence. Microbiol Spectr. 2022;10:e0270122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hernandez-Morfa M, Reinoso-Vizcaíno NM, Olivero NB, Zappia VE, Cortes PR, Jaime A, et al. Host cell oxidative stress promotes intracellular fluoroquinolone persisters of Streptococcus pneumoniae. Microbiol Spectr. 2022;10:e0436422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother. 2006;50:3839–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lafleur MD, Qi Q, Lewis K. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother. 2010;54:39–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kasper L, Seider K, Hube B. Intracellular survival of Candida Glabrata in macrophages: immune evasion and persistence. FEMS Yeast Res. 2015;15:fov042. [DOI] [PubMed] [Google Scholar]
- 39.Li P, Seneviratne CJ, Alpi E, Vizcaino JA, Jin L. Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans Biofilm persisters. Antimicrob Agents Chemother. 2015;59:6101–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.da Silva MA, Baronetti JL, Páez PL, Paraje MG. Oxidative imbalance in Candida tropicalis Biofilms and its relation with Persister cells. Front Microbiol. 2020;11:598834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol. 2016;1:16051. [DOI] [PubMed] [Google Scholar]
- 42.Chang J, Lee R-E, Lee W. A pursuit of Staphylococcus aureus continues: a role of persister cells. Arch Pharm Res. 2020;43:630–8. [DOI] [PubMed] [Google Scholar]
- 43.Goneau LW, Yeoh NS, MacDonald KW, Cadieux PA, Burton JP, Razvi H, et al. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother. 2014;58:2089–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yang S, Hay ID, Cameron DR, Speir M, Cui B, Su F, et al. Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms. Sci Rep. 2015;5:18578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Knudsen GM, Ng Y, Gram L. Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes. Appl Environ Microbiol. 2013;79:7390–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Grosboillot V, Keller I, Ernst C, Loessner MJ, Schuppler M. Ampicillin treatment of intracellular Listeria monocytogenes triggers formation of Persistent, Drug-resistant L-Form cells. Front Cell Infect Microbiol. 2022;12:869339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bakkeren E, Huisman JS, Fattinger SA, Hausmann A, Furter M, Egli A, et al. Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut. Nature. 2019;573:276–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Cao Z, Chen X, Chen J, Xia A, Bacacao B, Tran J, et al. Gold nanocluster adjuvant enables the eradication of persister cells by antibiotics and abolishes the emergence of resistance. Nanoscale. 2022;14:10016–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson DI, et al. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol. 2019;17:441–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Helaine S, Kugelberg E. Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol. 2014;22:417–24. [DOI] [PubMed] [Google Scholar]
- 51.Amato SM, Fazen CH, Henry TC, Mok WWK, Orman MA, Sandvik EL, et al. The role of metabolism in bacterial persistence. Front Microbiol. 2014;5:70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Orman MA, Brynildsen MP. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother. 2013;57:3230–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr. 2016;4. [DOI] [PMC free article] [PubMed]
- 54.Sophie H, Ja T, Kg W, Dw MLCB. H. Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci U S A. 2010;107. [DOI] [PMC free article] [PubMed]
- 55.Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol. 2016;14:320–30. [DOI] [PubMed] [Google Scholar]
- 56.Ramamurthy T, Ghosh A, Pazhani GP, Shinoda S. Current perspectives on viable but non-culturable (VBNC) pathogenic Bacteria. Front Public Health. 2014;2:103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Fleischmann S, Robben C, Alter T, Rossmanith P, Mester P. How to evaluate non-growing cells-current strategies for determining Antimicrobial Resistance of VBNC Bacteria. Antibiot Basel Switz. 2021;10:115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Ducret A, Chabalier M, Dukan S. Characterization and resuscitation of non-culturable cells of Legionella pneumophila. BMC Microbiol. 2014;14:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Morishige Y, Fujimori K, Amano F. Differential resuscitative effect of pyruvate and its analogues on VBNC (viable but non-culturable) Salmonella. Microbes Environ. 2013;28:180–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Pu Y, Li Y, Jin X, Tian T, Ma Q, Zhao Z, et al. ATP-Dependent dynamic protein aggregation regulates bacterial dormancy depth critical for antibiotic tolerance. Mol Cell. 2019;73:143–e1564. [DOI] [PubMed] [Google Scholar]
- 61.Jurėnas D, Fraikin N, Goormaghtigh F, Van Melderen L. Biology and evolution of bacterial toxin-antitoxin systems. Nat Rev Microbiol. 2022;20:335–50. [DOI] [PubMed] [Google Scholar]
- 62.Ronneau S, Helaine S. Clarifying the link between Toxin-Antitoxin modules and bacterial persistence. J Mol Biol. 2019;431:3462–71. [DOI] [PubMed] [Google Scholar]
- 63.Christensen SK, Maenhaut-Michel G, Mine N, Gottesman S, Gerdes K, Van Melderen L. Overproduction of the lon protease triggers inhibition of translation in Escherichia coli: involvement of the Yefm-Yoeb toxin-antitoxin system. Mol Microbiol. 2004;51:1705–17. [DOI] [PubMed] [Google Scholar]
- 64.Page R, Peti W. Toxin-antitoxin systems in bacterial growth arrest and persistence. Nat Chem Biol. 2016;12:208–14. [DOI] [PubMed] [Google Scholar]
- 65.Berghoff BA, Wagner EGH. RNA-based regulation in type I toxin-antitoxin systems and its implication for bacterial persistence. Curr Genet. 2017;63:1011–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Verstraeten N, Knapen WJ, Kint CI, Liebens V, Van den Bergh B, Dewachter L, et al. Obg and membrane depolarization are part of a Microbial bet-hedging strategy that leads to antibiotic tolerance. Mol Cell. 2015;59:9–21. [DOI] [PubMed] [Google Scholar]
- 67.Pj DWLD, C DL. B, N V, J M. HokB monomerization and membrane repolarization control Persister Awakening. Mol Cell. 2019;75. [DOI] [PubMed]
- 68.Moyed HS, Bertrand KP. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983;155:768–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Korch SB, Hill TM. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol. 2006;188:3826–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Kaspy I, Rotem E, Weiss N, Ronin I, Balaban NQ, Glaser G. HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun. 2013;4:3001. [DOI] [PubMed] [Google Scholar]
- 71.Hauryliuk V, Atkinson GC, Murakami KS, Tenson T, Gerdes K. Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nat Rev Microbiol. 2015;13:298–309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Winther K, Tree JJ, Tollervey D, Gerdes K. VapCs of Mycobacterium tuberculosis cleave RNAs essential for translation. Nucleic Acids Res. 2016;44:9860–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Cheverton AM, Gollan B, Przydacz M, Wong CT, Mylona A, Hare SA, et al. A Salmonella toxin promotes Persister formation through Acetylation of tRNA. Mol Cell. 2016;63:86–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Pedersen K, Zavialov AV, Pavlov MY, Elf J, Gerdes K, Ehrenberg M. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell. 2003;112:131–40. [DOI] [PubMed] [Google Scholar]
- 75.Hurley JM, Cruz JW, Ouyang M, Woychik NA. Bacterial toxin RelE mediates frequent codon-independent mRNA cleavage from the 5’ end of coding regions in vivo. J Biol Chem. 2011;286:14770–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Bezrukov F, Prados J, Renzoni A, Panasenko OO. MazF toxin causes alterations in Staphylococcus aureus transcriptome, translatome and proteome that underlie bacterial dormancy. Nucleic Acids Res. 2021;49:2085–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Gerdes K, Maisonneuve E. Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol. 2012;66:103–23. [DOI] [PubMed] [Google Scholar]
- 78.Vázquez-Laslop N, Lee H, Neyfakh AA. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol. 2006;188:3494–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Goormaghtigh F, Fraikin N, Putrinš M, Hallaert T, Hauryliuk V, Garcia-Pino A, et al. Reassessing the role of type II toxin-antitoxin systems in formation of Escherichia coli type II persister cells. mBio. 2018;9:e00640–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Gollan B, Grabe G, Michaux C, Helaine S. Bacterial persisters and infection: past, Present, and progressing. Annu Rev Microbiol. 2019;73:359–85. [DOI] [PubMed] [Google Scholar]
- 81.Potrykus K, Cashel M. (P)ppGpp: still magical? Annu Rev Microbiol. 2008;62:35–51. [DOI] [PubMed] [Google Scholar]
- 82.Srivatsan A, Wang JD. Control of bacterial transcription, translation and replication by (p)ppGpp. Curr Opin Microbiol. 2008;11:100–5. [DOI] [PubMed] [Google Scholar]
- 83.Kanjee U, Ogata K, Houry WA. Direct binding targets of the stringent response alarmone (p)ppGpp. Mol Microbiol. 2012;85:1029–43. [DOI] [PubMed] [Google Scholar]
- 84.Ao G, C C-W, Ja L. Many means to a common end: the intricacies of (p)ppGpp metabolism and its control of bacterial homeostasis. J Bacteriol. 2015;197. [DOI] [PMC free article] [PubMed]
- 85.Shimada T, Yoshida H, Ishihama A. Involvement of cyclic AMP receptor protein in regulation of the rmf gene encoding the ribosome modulation factor in Escherichia coli. J Bacteriol. 2013;195:2212–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Traxler MF, Summers SM, Nguyen H-T, Zacharia VM, Hightower GA, Smith JT, et al. The global, ppgpp-mediated stringent response to amino acid starvation in Escherichia coli. Mol Microbiol. 2008;68:1128–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.LeRoux M, Culviner PH, Liu YJ, Littlehale ML, Laub MT. Stress can induce transcription of Toxin-Antitoxin systems without activating toxin. Mol Cell. 2020;79:280–e2928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Van den Bergh B, Fauvart M, Michiels J. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol Rev. 2017;41:219–51. [DOI] [PubMed] [Google Scholar]
- 89.Dörr T, Lewis K, Vulić M. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 2009;5:e1000760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Baharoglu Z, Mazel D. SOS, the formidable strategy of bacteria against aggressions. FEMS Microbiol Rev. 2014;38:1126–45. [DOI] [PubMed] [Google Scholar]
- 91.Dörr T, Vulić M, Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010;8:e1000317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Secor PR, Michaels LA, Ratjen A, Jennings LK, Singh PK. Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2018;115:10780–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.McCourt J, O’Halloran DP, McCarthy H, O’Gara JP, Geoghegan JA. Fibronectin-binding proteins are required for biofilm formation by community-associated methicillin-resistant Staphylococcus aureus strain LAC. FEMS Microbiol Lett. 2014;353:157–64. [DOI] [PubMed] [Google Scholar]
- 94.Choudhary E, Sharma R, Kumar Y, Agarwal N. Conditional silencing by CRISPRi reveals the role of DNA gyrase in formation of drug-tolerant Persister Population in Mycobacterium tuberculosis. Front Cell Infect Microbiol. 2019;9:70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Prysak MH, Mozdzierz CJ, Cook AM, Zhu L, Zhang Y, Inouye M, et al. Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol Microbiol. 2009;71:1071–87. [DOI] [PubMed] [Google Scholar]
- 96.M K, L A, G S. An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol Microbiol. 2007;64. [DOI] [PMC free article] [PubMed]
- 97.Weel-Sneve R, Kristiansen KI, Odsbu I, Dalhus B, Booth J, Rognes T, et al. Single transmembrane peptide DinQ modulates membrane-dependent activities. PLoS Genet. 2013;9:e1003260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Unoson C, Wagner EGH. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol Microbiol. 2008;70:258–70. [DOI] [PubMed] [Google Scholar]
- 99.Edelmann D, Oberpaul M, Schäberle TF, Berghoff BA. Post-transcriptional deregulation of the tisB/istR-1 toxin-antitoxin system promotes SOS-independent persister formation in Escherichia coli. Environ Microbiol Rep. 2021;13:159–68. [DOI] [PubMed] [Google Scholar]
- 100.Berghoff BA, Hoekzema M, Aulbach L, Wagner EGH. Two regulatory RNA elements affect TisB-dependent depolarization and persister formation. Mol Microbiol. 2017;103:1020–33. [DOI] [PubMed] [Google Scholar]
- 101.Waldron D. Bacterial physiology: obg controls bacterial persistence. Nat Rev Microbiol. 2015;13:457. [DOI] [PubMed] [Google Scholar]
- 102.Li Y, Zhang Y. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother. 2007;51:2092–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Aurelia B. N M, S G. The RpoS-mediated general stress response in Escherichia coli. Annu Rev Microbiol. 2011;65. [DOI] [PMC free article] [PubMed]
- 104.Hansen S, Lewis K, Vulić M. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother. 2008;52:2718–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Samantha N, Kim L. The role of Integration Host Factor in Escherichia coli Persister formation. mBio. 2022;13. [DOI] [PMC free article] [PubMed]
- 106.Yan D, Zhang Q, Fu Q, Sun M, Huang X. Disruption of Fis reduces bacterial persister formation by regulating glutamate metabolism in Salmonella. Microb Pathog. 2021;152:104651. [DOI] [PubMed] [Google Scholar]
- 107.Rizvanovic A, Michaux C, Panza M, Iloglu Z, Helaine S, Wagner EGH, et al. The RNA-Binding protein ProQ promotes antibiotic persistence in Salmonella. mBio. 2022;13:e0289122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Ea Z, As N, Lc SMGC, Bp R. C, Stochastic variation in expression of the Tricarboxylic Acid Cycle produces Persister cells. mBio. 2019;10. [DOI] [PMC free article] [PubMed]
- 109.Quigley J, Lewis K. Noise in a metabolic pathway leads to Persister formation in Mycobacterium tuberculosis. Microbiol Spectr. 2022;10:e0294822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Kwan BW, Valenta JA, Benedik MJ, Wood TK. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother. 2013;57:1468–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Trastoy R, Manso T, Fernández-García L, Blasco L, Ambroa A, Del Pérez ML, et al. Mechanisms of bacterial tolerance and persistence in the gastrointestinal and respiratory environments. Clin Microbiol Rev. 2018;31:e00023–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Yi L, Dong X, Grenier D, Wang K, Wang Y. Research progress of bacterial quorum sensing receptors: classification, structure, function and characteristics. Sci Total Environ. 2021;763:143031. [DOI] [PubMed] [Google Scholar]
- 113.Fan Q, L JZHWDG. Y, Y W. Contribution of quorum sensing to virulence and antibiotic resistance in zoonotic bacteria. Biotechnol Adv. 2022;59. [DOI] [PubMed]
- 114.Fan Q, Wang H, Mao C, Li J, Zhang X, Grenier D, et al. Structure and Signal Regulation Mechanism of Interspecies and Interkingdom Quorum sensing System receptors. J Agric Food Chem. 2022;70:429–45. [DOI] [PubMed] [Google Scholar]
- 115.Tao X, Xy W, Ym PC, Wh Z. Z, Y Z. The Agr Quorum sensing System represses Persister formation through regulation of Phenol Soluble modulins in Staphylococcus aureus. Front Microbiol. 2017;8. [DOI] [PMC free article] [PubMed]
- 116.Bojer MS, Lindemose S, Vestergaard M, Ingmer H. Quorum sensing-regulated phenol-soluble modulins limit Persister Cell populations in Staphylococcus aureus. Front Microbiol. 2018;9:255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Wang Y, Liu B, Grenier D, Yi L. Regulatory mechanisms of the LuxS/AI-2 system and bacterial resistance. Antimicrob Agents Chemother. 2019;63:e01186–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Dufour D, Zhao H, Gong S-G, Lévesque CM. A DNA-Damage Inducible Gene promotes the formation of antibiotic persisters in response to the Quorum Sensing Signaling peptide in Streptococcus mutans. Genes. 2022;13:1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Fan Q, Zuo J, Wang H, Grenier D, Yi L, Wang Y. Contribution of quorum sensing to virulence and antibiotic resistance in zoonotic bacteria. Biotechnol Adv. 2022;59:107965. [DOI] [PubMed] [Google Scholar]
- 120.Möker N, Dean CR, Tao J. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol. 2010;192:1946–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Leung V, Lévesque CM. A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol. 2012;194:2265–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Zarkan A, Liu J, Matuszewska M, Gaimster H, Summers DK. Local and universal action: the paradoxes of Indole Signalling in Bacteria. Trends Microbiol. 2020;28:566–77. [DOI] [PubMed] [Google Scholar]
- 123.Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol. 2001;55:165–99. [DOI] [PubMed] [Google Scholar]
- 124.Vega NM, Allison KR, Khalil AS, Collins JJ. Signaling-mediated bacterial persister formation. Nat Chem Biol. 2012;8:431–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Hu Y, Kwan BW, Osbourne DO, Benedik MJ, Wood TK. Toxin YafQ increases persister cell formation by reducing indole signalling. Environ Microbiol. 2015;17:1275–85. [DOI] [PubMed] [Google Scholar]
- 126.Kwan BW, Osbourne DO, Hu Y, Benedik MJ, Wood TK. Phosphodiesterase DosP increases persistence by reducing cAMP which reduces the signal indole. Biotechnol Bioeng. 2015;112:588–600. [DOI] [PubMed] [Google Scholar]
- 127.Flemming H-C, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14:563–75. [DOI] [PubMed] [Google Scholar]
- 128.Yin W, Y W, Biofilms LLJH. The Microbial Protective Clothing in Extreme environments. Int J Mol Sci. 2019;20. [DOI] [PMC free article] [PubMed]
- 129.Gao M, Zuo J, Shen Y, Yuan S, Gao S, Wang Y, et al. Modeling co-infection by Streptococcus suis and Haemophilus parasuis reveals influences on Biofilm formation and host response. Anim Open Access J MDPI. 2023;13:1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Lebeaux D, Jm G. C B. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev MMBR. 2014;78. [DOI] [PMC free article] [PubMed]
- 131.Conlon BP, Rowe SE, Lewis K. Persister cells in biofilm associated infections. Adv Exp Med Biol. 2015;831:1–9. [DOI] [PubMed] [Google Scholar]
- 132.Mlynarcik P, Kolar M. Starvation- and antibiotics-induced formation of persister cells in Pseudomonas aeruginosa. Biomed Pap Med Fac Univ Palacky Olomouc Czechoslov. 2017;161:58–67. [DOI] [PubMed] [Google Scholar]
- 133.Yi L, Jin M, Li J, Grenier D, Wang Y. Antibiotic resistance related to biofilm formation in Streptococcus suis. Appl Microbiol Biotechnol. 2020;104:8649–60. [DOI] [PubMed] [Google Scholar]
- 134.Harms A, Maisonneuve E, Gerdes K. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science. 2016;354:aaf4268. [DOI] [PubMed] [Google Scholar]
- 135.Van Acker H, Sass A, Bazzini S, De Roy K, Udine C, Messiaen T, et al. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS ONE. 2013;8:e58943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Amato SM, Brynildsen MP. Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLoS ONE. 2014;9:e93110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Ps S. Antimicrobial tolerance in Biofilms. Microbiol Spectr. 2015;3. [DOI] [PMC free article] [PubMed]
- 138.Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45:999–1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Yan J, Bassler BL. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe. 2019;26:15–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Stapels DAC, Hill PWS, Westermann AJ, Fisher RA, Thurston TL, Saliba A-E, et al. Salmonella persisters undermine host immune defenses during antibiotic treatment. Science. 2018;362:1156–60. [DOI] [PubMed] [Google Scholar]
- 141.Eisenreich W, Rudel T, Heesemann J, Goebel W. Persistence of intracellular bacterial pathogens-with a focus on the metabolic perspective. Front Cell Infect Microbiol. 2020;10:615450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Karki P, Mohiuddin SG, Kavousi P, Orman MA. Investigating the effects of Osmolytes and Environmental pH on bacterial persisters. Antimicrob Agents Chemother. 2020;64:e02393–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Peyrusson F, Nguyen TK, Najdovski T, Van Bambeke F. Host cell oxidative stress induces dormant Staphylococcus aureus Persisters. Microbiol Spectr. 2022;10:e0231321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol. 2004;186:8172–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Keren I. S M, E R, K L. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio. 2011;2. [DOI] [PMC free article] [PubMed]
- 146.Van den Bergh B, Michiels JE, Wenseleers T, Windels EM, Boer PV, Kestemont D, et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol. 2016;1:16020. [DOI] [PubMed] [Google Scholar]
- 147.Henry TC, Brynildsen MP. Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity. Sci Rep. 2016;6:25100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Levin-Reisman I, Gefen O, Fridman O, Ronin I, Shwa D, Sheftel H, et al. Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes. Nat Methods. 2010;7:737–9. [DOI] [PubMed] [Google Scholar]
- 149.Orman MA, Brynildsen MP. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother. 2013;57:4398–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Mohiuddin SG, Kavousi P, Orman MA. Flow-cytometry analysis reveals persister resuscitation characteristics. BMC Microbiol. 2020;20:202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Srinivas V, Arrieta-Ortiz ML, Kaur A, Peterson EJR, Baliga NS. PerSort facilitates characterization and elimination of Persister Subpopulation in Mycobacteria. mSystems. 2020;5:e01127–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Wagley S, A K-S HM, Zr Y, A P, Rk T et al. Bacterial dormancy: a subpopulation of viable but non-culturable cells demonstrates better fitness for revival. PLoS Pathog. 2021;17. [DOI] [PMC free article] [PubMed]
- 153.Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. Persisters: a distinct physiological state of E. Coli. BMC Microbiol. 2006;6:53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Amato SM, Orman MA, Brynildsen MP. Metabolic control of persister formation in Escherichia coli. Mol Cell. 2013;50:475–87. [DOI] [PubMed] [Google Scholar]
- 155.Völzing KG, Brynildsen MP. Stationary-phase persisters to Ofloxacin sustain DNA damage and require Repair systems only during recovery. mBio. 2015;6:e00731–00715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Gefen O, Gabay C, Mumcuoglu M, Engel G, Balaban NQ. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc Natl Acad Sci U S A. 2008;105:6145–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Smith R, Wright KL, Ashton L. Raman spectroscopy: an evolving technique for live cell studies. Analyst. 2016;141:3590–600. [DOI] [PubMed] [Google Scholar]
- 158.He Y, Zhang P, Huang S, Wang T, Ji Y, Xu J. Label-free, simultaneous quantification of starch, protein and triacylglycerol in single microalgal cells. Biotechnol Biofuels. 2017;10:275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Germond A, Ichimura T, Horinouchi T, Fujita H, Furusawa C, Watanabe TM. Raman spectral signature reflects transcriptomic features of antibiotic resistance in Escherichia coli. Commun Biol. 2018;1:85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Verma T, Annappa H, Singh S, Umapathy S, Nandi D. Profiling antibiotic resistance in Escherichia coli strains displaying differential antibiotic susceptibilities using Raman spectroscopy. J Biophotonics. 2021;14:e202000231. [DOI] [PubMed] [Google Scholar]
- 161.García-Timermans C, Props R, Zacchetti B, Sakarika M, Delvigne F, Boon N. Raman Spectroscopy-based measurements of single-cell phenotypic diversity in microbial populations. mSphere. 2020;5:e00806–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Wang C, Chen R, Xu J, Jin L. Single-cell Raman spectroscopy identifies Escherichia coli persisters and reveals their enhanced metabolic activities. Front Microbiol. 2022;13:936726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Blattman SB, Jiang W, Oikonomou P, Tavazoie S. Prokaryotic single-cell RNA sequencing by in situ combinatorial indexing. Nat Microbiol. 2020;5:1192–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Karki P, Angardi V, Mier JC, Orman MA. A transient metabolic state in Melanoma Persister cells mediated by chemotherapeutic treatments. Front Mol Biosci. 2021;8:780192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Kalkavan H, Chen MJ, Crawford JC, Quarato G, Fitzgerald P, Tait SWG, et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell. 2022;185:3356–e337422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Cabanos HF, Hata AN. Emerging insights into targeted therapy-tolerant Persister cells in Cancer. Cancers. 2021;13:2666. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No datasets were generated or analysed during the current study.





